Developer docs
API playgroundTry for free, no card

Search company profiles

ichorbio

Full company profile

uuid000opod

Namestring
ichorbio
Legal namestring
ichorbio Ltd
Websiteurl
ichor.bio
Company typeenum
Private
Founded yearint
2019
Descriptiontext

ichorbio Ltd is a privately held UK-based biotechnology company headquartered in Wantage, Oxfordshire, specializing in the manufacture and direct-to-customer sale of research-grade antibodies and biosimilars for preclinical research applications. The company operates a comprehensive catalog of 352+ products spanning in vivo antibodies (with low and ultra-low endotoxin specifications), research biosimilars, monoclonal and recombinant antibodies, isotype controls, bispecific antibodies, antibody drug conjugates (ADCs), recombinant proteins, and auxiliary reagents such as D-Luciferin and in vivo buffers. Core technical capabilities include recombinant antibody production to avoid hybridoma drift, IDEXX IMPACT pathogen testing for guaranteed pathogen-free ultra-low endotoxin products, and manufacturing at scales ranging from milligram to gram quantities to support high-throughput and bulk experimental needs.

The company's business model is anchored on a self-serve e-commerce storefront at ichor.bio with multi-currency support (USD, GBP, EUR), a quote-based process for bulk and custom orders, and a minimum order value of £75. Pricing is unit-based across tiers: research biosimilars ($102–$9,364+), in vivo antibodies ($150–$23,460+), and isotype controls ($129–$23,460), with a 5% promotional discount available (code ONLINE5). ichorbio explicitly positions itself as a cost-competitive alternative to Bio X Cell, claiming up to 37% cost savings for industry customers and 36% on ultra-low endotoxin versions, supported by a content marketing strategy that drives comparison-page traffic from researchers facing incumbent price increases.

The customer base is horizontally segmented across academic and university research institutions, biotechnology companies requiring bulk supply, and contract research organizations (CROs). Products are cited in research from global institutions including Hanyang University, Max Planck Institute, University of Queensland, University of Toronto, Nanyang Technological University, and others across Asia, Europe, North America, and Oceania. The company sells exclusively for research use only (RUO), not for therapeutic or diagnostic use, and supports demand generation through educational content, email campaigns, technical datasheets, and direct comparison content targeting researchers considering supplier switches.

Short descriptiontext

ichorbio Ltd is a UK-based biotechnology company that manufactures and sells research-grade antibodies, biosimilars, isotype controls, and recombinant proteins through a direct e-commerce platform, serving academic researchers, biotechnology companies, and contract research organizations globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOxford, United Kingdom
HQ citystring
Oxford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
research antibodies, in vivo antibodies, research biosimilars, monoclonal antibodies, recombinant proteins
Industry3 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Biological Products, (No Disgnostic Substances)2836
Product category
Research Antibodies and Biosimilars
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Research Antibodies and Biosimilars Sales
TypeOne Time License
Description

One-time sale of research-grade antibodies and biosimilars for preclinical research use. Products sold in various sizes from 1mg to 500mg and 1g quantities. Products are sold for research purposes only, not for therapeutic or diagnostic use.

ichor.bio
2Bulk and Custom Antibody Manufacturing
TypeOne Time License
Description

Scalable bulk supply capabilities for biotechnology companies and contract research organizations requiring gram-scale quantities for process development and manufacturing.

ichor.bio
3Custom Services
TypeProfessional Services
Description

Custom monoclonal antibody expression service for specialized research needs beyond catalog offerings.

ichor.bio
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others
Pricing details5 tiers
1Research Biosimilars - Price varies by product, ranging from $102 to $9,364+ depending on antibody type and quantity
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Biosimilar products priced per unit with options for different quantities. Example: Ragifilimab Biosimilar $102, Ivonescimab Biosimilar $365-$9,364, Sonesitatug Biosimilar $315-$5,200.

ichor.bio
2In Vivo Antibodies - Price ranges from $150 to $23,460+ depending on clone and size
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Low endotoxin in vivo antibodies available in sizes from 1mg to 500mg and 1g. Example: Anti-Mouse PD-1 (29F.1A12) $150-$23,460.

ichor.bio
3Isotype Controls - Prices range from $129 to $23,460 depending on specification
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Isotype controls available as low endotoxin or ultra-low endotoxin variants. Mouse IgG2a Isotype Control $937-$2,530, Mouse IgG2a (C1.18.4) Isotype Control $129-$23,460.

ichor.bio
4Auxiliary Reagents - Supporting products like D Luciferin and buffers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

In Vivo Buffer pH7.2 $112.50 (50ml), D Luciferin $400-$3,672 (10g).

ichor.bio
5Ultra-Low Endotoxin Premium Products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Premium pricing for ultra-low endotoxin versions (<0.5 EU/mg) with higher purity (98% vs 95%) compared to standard low endotoxin versions.

ichor.bio
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ichorbio manufactures and sells research-grade monoclonal antibodies, recombinant antibodies, and antibody biosimilars for preclinical and in vivo research applications. Its catalog spans over 350 products, covering cell-line authentication reagents, tag antibodies, isotype controls, recombinant proteins, bispecific antibodies, ADCs, Fc-silenced antibodies, and ancillary reagents, with bulk (milligram to gram) supply and custom antibody expression services available.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Up to 37% cost savings for industry compared to Bio X Cell equivalent products
+1 more record
Product overview1 text field

ichorbio is a biotechnology company specializing in research-grade antibodies and biosimilars for preclinical and in vitro research applications. The portfolio is organized around several core product lines: In Vivo Antibodies (validated for animal studies with low/ultra-low endotoxin), Research Biosimilars (including unconjugated biosimilars, bispecific antibodies, and ADC conjugates), Monoclonal and Recombinant Antibodies, Isotype Controls in multiple species formats, and Auxiliary Reagents. Key products include the RMP1-14 anti-PD-1 antibody, PD-1/PD-L1 pathway antibodies, and over 300 cited research area products. The company offers bulk quantities from milligram to gram scale, with Fc-silenced variants (LALAPG, D265A) and specialized Research Panels for oncology and other therapeutic areas. Products are for research use only (RUO), not for therapeutic or diagnostic applications.

Product and service17 records
1In Vivo Antibodies
CategoryResearch antibodies
Description

In Vivo Antibodies are research-grade and in vivo-grade antibody reagents (monoclonal and recombinant, including Fc-silenced clones) intended for administration in preclinical animal studies, sold in bulk quantities with low endotoxin and pathogen-testing specifications.

2Research Biosimilars
CategoryBiosimilars
Description

Research Biosimilars are antibody biosimilars replicating approved therapeutic antibody reference products, supplied for preclinical research and in vivo comparator studies rather than clinical use.

3Monoclonal Antibodies
CategoryMonoclonal antibodies
Description

Monoclonal Antibodies offered by ichorbio are research-grade mAbs targeting cell-surface and soluble antigens, supplied for in vitro and in vivo research applications.

4Recombinant Antibodies
CategoryRecombinant antibodies
Description

Recombinant Antibodies are engineered, defined-sequence antibody reagents developed through recombinant expression systems for consistent specificity in research applications.

5Recombinant Proteins
CategoryRecombinant proteins
Description

Recombinant Proteins are expressed protein reagents used to support immunological and biochemical research workflows such as assay development and target studies.

6Tag Antibodies
CategoryTag antibodies
Description

Tag Antibodies are reagents targeting common epitope tags (e.g., His, FLAG, HA, Myc, GST) used to detect tagged recombinant proteins in research assays.

7Auxiliary Reagents
CategoryAuxiliary reagents
Description

Auxiliary Reagents are supporting buffers, diluents, and related reagents used to facilitate antibody-based research workflows and assay preparation.

8Isotype Controls
CategoryIsotype controls
Description

Isotype Controls are non-targeting, species- and isotype-matched antibody reagents used as negative controls in flow cytometry, immunohistochemistry, and in vivo studies.

9Bispecific Antibodies
CategoryBispecific antibodies
Description

Bispecific Antibodies are dual-binding engineered antibody reagents designed for research applications requiring simultaneous recognition of two targets.

10Antibody-Drug Conjugates (ADCs)
CategoryAntibody-drug conjugates
Description

Antibody-Drug Conjugates (ADCs) supplied by ichorbio are research-use conjugates combining targeting antibodies with cytotoxic payloads for preclinical ADC research and development.

11Fc-Silenced Antibodies
CategoryEngineered antibodies
Description

Fc-Silenced Antibodies are engineered antibody reagents in which Fc-receptor and complement-binding functions have been reduced, used in research where effector function would confound interpretation.

12Custom Antibody Expression Service
CategoryCustom antibody services
Description

Custom Antibody Expression is a fee-for-service offering that engineers and expresses client-specified recombinant antibodies and proteins for research applications.

13Research Panels
CategoryResearch antibody bundles
Description

Research Panels are curated bundles of related antibody reagents assembled for specific research applications such as immune checkpoint or T-cell phenotyping studies.

14RMP1-14 Anti-Mouse PD-1 Antibody (In Vivo)
CategoryIn vivo monoclonal antibodies
Description

RMP1-14 is an in vivo-grade rat anti-mouse PD-1 monoclonal antibody clone supplied for preclinical studies involving PD-1 checkpoint blockade.

15Pivekimab Biosimilar
CategoryResearch biosimilars
Description

The Pivekimab Biosimilar is a research-grade antibody designed as a biosimilar of the Pivekimab reference therapeutic for preclinical comparator studies.

16Bulk Anti-Human CD18 (IB4) Antibody
CategoryResearch antibodies
Description

Bulk Anti-Human CD18 (IB4) Antibody is a research-grade monoclonal antibody targeting human CD18, supplied in bulk quantities for preclinical and in vivo studies.

17Idiotype Antibodies
CategoryResearch antibodies
Description

Idiotype Antibodies are reagents used to study immunoglobulin clonality, repertoire, and B-cell populations in research contexts.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Bio X Cell
TypeDirect peer
Description

Bio X Cell is the most direct competitor to ichorbio, specializing in low-endotoxin in vivo-grade monoclonal antibodies for preclinical research. The two companies compete head-to-head on identical clones (e.g., anti-PD-1), and ichorbio explicitly markets its 37% cost advantage against Bio X Cell pricing.

TypeBroad incumbent
Description

Cell Signaling Technology is a major established research antibody provider with broad coverage across immunology, oncology, and cell signaling. While CST focuses more on in vitro applications, it is a comparable research reagent supplier with similar catalog breadth and academic customer base.

TypeBroad incumbent
Description

Abcam is one of the largest research antibody suppliers globally, acquired by Danaher. It serves the same academic and biotech customer base as ichorbio with a much broader catalog, though Abcam's primary focus is in vitro applications rather than in vivo-grade reagents.

TypeBroad incumbent
Description

BioLegend is a large research antibody supplier with strong coverage in flow cytometry and immunology reagents. It serves the same academic and biotech customer base with broader catalog and brand recognition, though it does not specialize in in vivo-grade antibodies to the same extent as ichorbio.

5Santa Cruz Biotechnology
TypeBroad incumbent
Description

Santa Cruz Biotechnology is a long-established research antibody supplier with an extensive catalog. It competes with ichorbio in monoclonal and recombinant antibody categories, particularly for academic customers, though it has different strengths in application areas.

TypeBroad incumbent
Description

Bio-Techne, including R&D Systems, is a leading research reagent supplier offering antibodies, proteins, and assays. It overlaps with ichorbio in recombinant proteins and antibodies, with much broader product portfolio and stronger brand in the academic research market.

TypeEmerging player
Description

GenScript is a global biotech offering research antibody services, recombinant protein production, and biosimilar reagents. It overlaps with ichorbio in recombinant antibody manufacturing and is a competitive supplier in the bulk and custom antibody segment, particularly with biotech customers.

TypeEmerging player
Description

Sino Biological is a Chinese-based research reagent supplier offering recombinant antibodies, proteins, and other reagents. It competes with ichorbio on catalog recombinant antibodies and price-sensitive segments, with particular strength in recombinant protein and antibody expression services.

9InvivoGen
TypeDirect peer
Description

InvivoGen supplies research antibodies, cell lines, and reagents for immunology and cell biology research. It is a direct peer in the in vivo reagent space serving similar academic and biotech customers, with overlap in isotype controls and immune checkpoint antibodies.

TypeEmerging player
Description

Proteintech is a research antibody supplier with a strong catalog of polyclonal and monoclonal antibodies. It overlaps with ichorbio in catalog recombinant antibodies and is increasingly competitive in the academic research market with similar pricing positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ichorbio

Research Antibodies and Biosimilarsichor.bio

ichorbio Ltd is a UK-based biotechnology company that manufactures and sells research-grade antibodies, biosimilars, isotype controls, and recombinant proteins through a direct e-commerce platform, serving academic researchers, biotechnology companies, and contract research organizations globally.

What ichorbio does

ichorbio Ltd is a privately held UK-based biotechnology company headquartered in Wantage, Oxfordshire, specializing in the manufacture and direct-to-customer sale of research-grade antibodies and biosimilars for preclinical research applications. The company operates a comprehensive catalog of 352+ products spanning in vivo antibodies (with low and ultra-low endotoxin specifications), research biosimilars, monoclonal and recombinant antibodies, isotype controls, bispecific antibodies, antibody drug conjugates (ADCs), recombinant proteins, and auxiliary reagents such as D-Luciferin and in vivo buffers. Core technical capabilities include recombinant antibody production to avoid hybridoma drift, IDEXX IMPACT pathogen testing for guaranteed pathogen-free ultra-low endotoxin products, and manufacturing at scales ranging from milligram to gram quantities to support high-throughput and bulk experimental needs.

The company's business model is anchored on a self-serve e-commerce storefront at ichor.bio with multi-currency support (USD, GBP, EUR), a quote-based process for bulk and custom orders, and a minimum order value of £75. Pricing is unit-based across tiers: research biosimilars ($102–$9,364+), in vivo antibodies ($150–$23,460+), and isotype controls ($129–$23,460), with a 5% promotional discount available (code ONLINE5). ichorbio explicitly positions itself as a cost-competitive alternative to Bio X Cell, claiming up to 37% cost savings for industry customers and 36% on ultra-low endotoxin versions, supported by a content marketing strategy that drives comparison-page traffic from researchers facing incumbent price increases.

The customer base is horizontally segmented across academic and university research institutions, biotechnology companies requiring bulk supply, and contract research organizations (CROs). Products are cited in research from global institutions including Hanyang University, Max Planck Institute, University of Queensland, University of Toronto, Nanyang Technological University, and others across Asia, Europe, North America, and Oceania. The company sells exclusively for research use only (RUO), not for therapeutic or diagnostic use, and supports demand generation through educational content, email campaigns, technical datasheets, and direct comparison content targeting researchers considering supplier switches.

ichorbio firmographics

Firmographics
Name
ichorbio
Legal name
ichorbio Ltd
Website
https://ichor.bio
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
ichorbio Ltd is a UK-based biotechnology company that manufactures and sells research-grade antibodies, biosimilars, isotype controls, and recombinant proteins through a direct e-commerce platform, serving academic researchers, biotechnology companies, and contract research organizations globally.
Ownership category
akta.pro rank

ichorbio industry classification

Industry
Product category
Research Antibodies and Biosimilars
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Research antibodies
  • In vivo antibodies
  • Research biosimilars
  • Monoclonal antibodies
  • Recombinant proteins

Where ichorbio is headquartered

Location

Headquarters

HQ city
Oxford
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

ichorbio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Research Antibodies and Biosimilars Sales: One-time sale of research-grade antibodies and biosimilars for preclinical research use. Products sold in various sizes from 1mg to 500mg and 1g quantities. Products are sold for research purposes only, not for therapeutic or diagnostic use.
  2. Bulk and Custom Antibody Manufacturing: Scalable bulk supply capabilities for biotechnology companies and contract research organizations requiring gram-scale quantities for process development and manufacturing.
  3. Custom Services: Custom monoclonal antibody expression service for specialized research needs beyond catalog offerings.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goResearch Biosimilars - Price varies by product, ranging from $102 to $9,364+ depending on antibody type and quantity
Unit PricingPay-as-you-goIn Vivo Antibodies - Price ranges from $150 to $23,460+ depending on clone and size
Unit PricingPay-as-you-goIsotype Controls - Prices range from $129 to $23,460 depending on specification
Unit PricingPay-as-you-goAuxiliary Reagents - Supporting products like D Luciferin and buffers
Unit PricingPay-as-you-goUltra-Low Endotoxin Premium Products

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

ichorbio product offering

Product offering

Core offering

ichorbio manufactures and sells research-grade monoclonal antibodies, recombinant antibodies, and antibody biosimilars for preclinical and in vivo research applications. Its catalog spans over 350 products, covering cell-line authentication reagents, tag antibodies, isotype controls, recombinant proteins, bispecific antibodies, ADCs, Fc-silenced antibodies, and ancillary reagents, with bulk (milligram to gram) supply and custom antibody expression services available.

Product overview

ichorbio is a biotechnology company specializing in research-grade antibodies and biosimilars for preclinical and in vitro research applications. The portfolio is organized around several core product lines: In Vivo Antibodies (validated for animal studies with low/ultra-low endotoxin), Research Biosimilars (including unconjugated biosimilars, bispecific antibodies, and ADC conjugates), Monoclonal and Recombinant Antibodies, Isotype Controls in multiple species formats, and Auxiliary Reagents. Key products include the RMP1-14 anti-PD-1 antibody, PD-1/PD-L1 pathway antibodies, and over 300 cited research area products. The company offers bulk quantities from milligram to gram scale, with Fc-silenced variants (LALAPG, D265A) and specialized Research Panels for oncology and other therapeutic areas. Products are for research use only (RUO), not for therapeutic or diagnostic applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • In Vivo Antibodies In Vivo Antibodies are research-grade and in vivo-grade antibody reagents (monoclonal and recombinant, including Fc-silenced clones) intended for administration in preclinical animal studies, sold in bulk quantities with low endotoxin and pathogen-testing specifications.
  • Research Biosimilars Research Biosimilars are antibody biosimilars replicating approved therapeutic antibody reference products, supplied for preclinical research and in vivo comparator studies rather than clinical use.
  • Monoclonal Antibodies Monoclonal Antibodies offered by ichorbio are research-grade mAbs targeting cell-surface and soluble antigens, supplied for in vitro and in vivo research applications.
  • Recombinant Antibodies Recombinant Antibodies are engineered, defined-sequence antibody reagents developed through recombinant expression systems for consistent specificity in research applications.
  • Recombinant Proteins Recombinant Proteins are expressed protein reagents used to support immunological and biochemical research workflows such as assay development and target studies.
  • Tag Antibodies Tag Antibodies are reagents targeting common epitope tags (e.g., His, FLAG, HA, Myc, GST) used to detect tagged recombinant proteins in research assays.
  • Auxiliary Reagents Auxiliary Reagents are supporting buffers, diluents, and related reagents used to facilitate antibody-based research workflows and assay preparation.
  • Isotype Controls Isotype Controls are non-targeting, species- and isotype-matched antibody reagents used as negative controls in flow cytometry, immunohistochemistry, and in vivo studies.
  • Bispecific Antibodies Bispecific Antibodies are dual-binding engineered antibody reagents designed for research applications requiring simultaneous recognition of two targets.
  • Antibody-Drug Conjugates (ADCs) Antibody-Drug Conjugates (ADCs) supplied by ichorbio are research-use conjugates combining targeting antibodies with cytotoxic payloads for preclinical ADC research and development.
  • Fc-Silenced Antibodies Fc-Silenced Antibodies are engineered antibody reagents in which Fc-receptor and complement-binding functions have been reduced, used in research where effector function would confound interpretation.
  • Custom Antibody Expression Service Custom Antibody Expression is a fee-for-service offering that engineers and expresses client-specified recombinant antibodies and proteins for research applications.
  • Research Panels Research Panels are curated bundles of related antibody reagents assembled for specific research applications such as immune checkpoint or T-cell phenotyping studies.
  • RMP1-14 Anti-Mouse PD-1 Antibody (In Vivo) RMP1-14 is an in vivo-grade rat anti-mouse PD-1 monoclonal antibody clone supplied for preclinical studies involving PD-1 checkpoint blockade.
  • Pivekimab Biosimilar The Pivekimab Biosimilar is a research-grade antibody designed as a biosimilar of the Pivekimab reference therapeutic for preclinical comparator studies.
  • Bulk Anti-Human CD18 (IB4) Antibody Bulk Anti-Human CD18 (IB4) Antibody is a research-grade monoclonal antibody targeting human CD18, supplied in bulk quantities for preclinical and in vivo studies.
  • Idiotype Antibodies Idiotype Antibodies are reagents used to study immunoglobulin clonality, repertoire, and B-cell populations in research contexts.

Quantifiable outcome

  • Up to 37% cost savings for industry compared to Bio X Cell equivalent products
  • +1 more outcomes

Companies that use ichorbio

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles3 records

ichorbio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

ichorbio partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

ichorbio competitors and assessment

Company assessment

Direct peers

  • Bio X Cell: Bio X Cell is the most direct competitor to ichorbio, specializing in low-endotoxin in vivo-grade monoclonal antibodies for preclinical research. The two companies compete head-to-head on identical clones (e.g., anti-PD-1), and ichorbio explicitly markets its 37% cost advantage against Bio X Cell pricing.
  • InvivoGen: InvivoGen supplies research antibodies, cell lines, and reagents for immunology and cell biology research. It is a direct peer in the in vivo reagent space serving similar academic and biotech customers, with overlap in isotype controls and immune checkpoint antibodies.

Broad incumbents

  • Cell Signaling Technology: Cell Signaling Technology is a major established research antibody provider with broad coverage across immunology, oncology, and cell signaling. While CST focuses more on in vitro applications, it is a comparable research reagent supplier with similar catalog breadth and academic customer base.
  • Abcam (Danaher): Abcam is one of the largest research antibody suppliers globally, acquired by Danaher. It serves the same academic and biotech customer base as ichorbio with a much broader catalog, though Abcam's primary focus is in vitro applications rather than in vivo-grade reagents.
  • BioLegend (part of Revvity): BioLegend is a large research antibody supplier with strong coverage in flow cytometry and immunology reagents. It serves the same academic and biotech customer base with broader catalog and brand recognition, though it does not specialize in in vivo-grade antibodies to the same extent as ichorbio.
  • Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established research antibody supplier with an extensive catalog. It competes with ichorbio in monoclonal and recombinant antibody categories, particularly for academic customers, though it has different strengths in application areas.
  • Bio-Techne (R&D Systems): Bio-Techne, including R&D Systems, is a leading research reagent supplier offering antibodies, proteins, and assays. It overlaps with ichorbio in recombinant proteins and antibodies, with much broader product portfolio and stronger brand in the academic research market.

Emerging players

  • GenScript: GenScript is a global biotech offering research antibody services, recombinant protein production, and biosimilar reagents. It overlaps with ichorbio in recombinant antibody manufacturing and is a competitive supplier in the bulk and custom antibody segment, particularly with biotech customers.
  • Sino Biological: Sino Biological is a Chinese-based research reagent supplier offering recombinant antibodies, proteins, and other reagents. It competes with ichorbio on catalog recombinant antibodies and price-sensitive segments, with particular strength in recombinant protein and antibody expression services.
  • Proteintech: Proteintech is a research antibody supplier with a strong catalog of polyclonal and monoclonal antibodies. It overlaps with ichorbio in catalog recombinant antibodies and is increasingly competitive in the academic research market with similar pricing positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

ichorbio social profiles

Digital presence

ichorbio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ichorbio leadership team

Management profile

Number of profiles

ichorbio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ichorbio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ichorbio

What does ichorbio do?

ichorbio manufactures and sells research-grade monoclonal antibodies, recombinant antibodies, and antibody biosimilars for preclinical and in vivo research applications. Its catalog spans over 350 products, covering cell-line authentication reagents, tag antibodies, isotype controls, recombinant proteins, bispecific antibodies, ADCs, Fc-silenced antibodies, and ancillary reagents, with bulk (milligram to gram) supply and custom antibody expression services available.

Is ichorbio a public or private company?

ichorbio is a private company. It is classified as unknown and is currently operating.

When was ichorbio founded?

ichorbio was founded in 2019. It employs 1 to 10 people.

Where is ichorbio based?

ichorbio is headquartered in Oxford, United Kingdom, in the Europe region.

How does ichorbio make money?

Three revenue lines are on record. Research Antibodies and Biosimilars Sales are the primary driver. The others are bulk and Custom Antibody Manufacturing and custom Services.

Who are ichorbio's main competitors?

Direct peers on record are Bio X Cell and InvivoGen. Broad incumbents are Cell Signaling Technology, Abcam (Danaher), BioLegend (part of Revvity), Santa Cruz Biotechnology and Bio-Techne (R&D Systems). Emerging players are GenScript, Sino Biological and Proteintech.

Does ichorbio have an API?

No public API is recorded for ichorbio.

What industry is ichorbio in?

ichorbio's product category is Research Antibodies and Biosimilars. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals